France

Restricted transitional medical access

France has a cannabis-medicine framework in its Public Health Code and a tightly restricted transition route for patients from the national medical cannabis experiment while the permanent system is completed.

The purchase rule

What consumers need to know

There is no general enrolment or adult-use market. Access is limited to the authorized medical pathway and eligible patients under the current transition rules.

Classification, not legal advice.

Cannabis rules change and may differ by region, municipality, product, age, residence, medical status, or licence type. Check the linked regulator before possessing, purchasing, cultivating, or travelling with cannabis.

Compare all legal markets →